James E Flynn Insider Trading $SLXP SALIX PHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in SALIX PHARMACEUTICALS LTD ($SLXP) and 10% Owner in ANADYS PHARMACEUTICALS INC ($ANDS) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Invitae Corp ($NVTA).
James E Flynn in SALIX PHARMACEUTICALS LTD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,941,480 shares
Latest Transaction: Sep 10 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in SALIX PHARMACEUTICALS LTD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANDS, AUXL, CAMY.OB, DRNA, EHTH, NVTA, PRX, TARA, SLXP, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.16 | 133,445 | 1,756,136 | 2,941,480 | 3.1 M to 2.9 M (-4.34 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.16 | 66,555 | 875,864 | 1,928,520 | 2 M to 1.9 M (-3.34 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 33,361 | 435,695 | 3,074,925 | 3.1 M to 3.1 M (-1.07 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 16,639 | 217,305 | 1,995,075 | 2 M to 2 M (-0.83 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.01 | 200,168 | 2,604,186 | 3,108,286 | 3.3 M to 3.1 M (-6.05 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.01 | 99,832 | 1,298,814 | 2,011,714 | 2.1 M to 2 M (-4.73 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.49 | 64,720 | 873,073 | 3,308,454 | 3.4 M to 3.3 M (-1.92 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.49 | 32,280 | 435,457 | 2,111,546 | 2.1 M to 2.1 M (-1.51 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 41,980 | 548,259 | 3,373,174 | 3.4 M to 3.4 M (-1.23 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 20,937 | 273,437 | 2,143,826 | 2.2 M to 2.1 M (-0.97 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.32 | 22,782 | 303,456 | 3,415,154 | 3.4 M to 3.4 M (-0.66 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.32 | 11,361 | 151,329 | 2,164,763 | 2.2 M to 2.2 M (-0.52 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 145,704 | 1,891,238 | 3,437,936 | 3.6 M to 3.4 M (-4.07 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.96 | 25,000 | 324,000 | 3,583,640 | 3.6 M to 3.6 M (-0.69 %) |
| Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 111,189 | 1,443,233 | 3,608,640 | 3.7 M to 3.6 M (-2.99 %) |
| Aug 20 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 10,921 | 141,755 | 3,719,829 | 3.7 M to 3.7 M (-0.29 %) |
| Aug 20 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.96 | 70,000 | 907,200 | 3,730,750 | 3.8 M to 3.7 M (-1.84 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | S | 12.55 | 14,852 | 186,393 | 3,800,750 | 3.8 M to 3.8 M (+0.39 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.55 | 9,901 | 124,258 | 2,176,124 | 2.2 M to 2.2 M (-0.45 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | S | 12.98 | 113,182 | 1,469,102 | 3,815,602 | 3.7 M to 3.8 M (+3.06 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 75,448 | 979,315 | 2,186,025 | 2.3 M to 2.2 M (-3.34 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.11 | 86,540 | 1,134,539 | 3,928,784 | 4 M to 3.9 M (-2.16 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.11 | 57,689 | 756,303 | 2,261,473 | 2.3 M to 2.3 M (-2.49 %) |
| Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 21,588 | 184,362 | 3,957,249 | 3.9 M to 4 M (+0.55 %) |
| Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 12,462 | 106,425 | 2,285,637 | 2.3 M to 2.3 M (+0.55 %) |
| Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.87 | 22,190 | 196,825 | 3,935,661 | 3.9 M to 3.9 M (+0.57 %) |
| Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.87 | 12,810 | 113,625 | 2,273,175 | 2.3 M to 2.3 M (+0.57 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 381 | 3,254 | 3,717,944 | 3.7 M to 3.7 M (+0.01 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 219 | 1,870 | 2,147,492 | 2.1 M to 2.1 M (+0.01 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.33 | 3,424 | 28,522 | 3,717,563 | 3.7 M to 3.7 M (+0.09 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.33 | 1,976 | 16,460 | 2,147,273 | 2.1 M to 2.1 M (+0.09 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.40 | 57,061 | 479,312 | 3,714,139 | 3.7 M to 3.7 M (+1.56 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.40 | 32,939 | 276,688 | 2,145,297 | 2.1 M to 2.1 M (+1.56 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 28,471 | 243,142 | 3,657,078 | 3.6 M to 3.7 M (+0.78 %) |
| Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 16,435 | 140,355 | 2,112,358 | 2.1 M to 2.1 M (+0.78 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.48 | 54,409 | 461,388 | 3,628,607 | 3.6 M to 3.6 M (+1.52 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.48 | 31,409 | 266,348 | 2,095,523 | 2.1 M to 2.1 M (+1.52 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.53 | 9,570 | 81,632 | 3,574,198 | 3.6 M to 3.6 M (+0.27 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.53 | 5,524 | 47,120 | 2,064,514 | 2.1 M to 2.1 M (+0.27 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 20,289 | 171,848 | 3,564,628 | 3.5 M to 3.6 M (+0.57 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 11,711 | 99,192 | 2,058,990 | 2 M to 2.1 M (+0.57 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 33,308 | 283,784 | 3,544,339 | 3.5 M to 3.5 M (+0.95 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 19,227 | 163,814 | 2,047,279 | 2 M to 2 M (+0.95 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.04 | 10,588 | 85,128 | 3,511,031 | 3.5 M to 3.5 M (+0.30 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.04 | 6,112 | 49,140 | 2,028,052 | 2 M to 2 M (+0.30 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 7.78 | 135,009 | 1,050,370 | 3,500,443 | 3.4 M to 3.5 M (+4.01 %) |
| Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 7.78 | 77,938 | 606,358 | 2,021,940 | 1.9 M to 2 M (+4.01 %) |
| Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 63,401 | 537,006 | 3,913,471 | 3.9 M to 3.9 M (+1.65 %) |
| Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 36,599 | 309,994 | 2,260,365 | 2.2 M to 2.3 M (+1.65 %) |
| Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 5,326 | 45,111 | 3,850,070 | 3.8 M to 3.9 M (+0.14 %) |
| Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 3,074 | 26,037 | 2,223,766 | 2.2 M to 2.2 M (+0.14 %) |
| Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 126,800 | 1,080,336 | 3,844,744 | 3.7 M to 3.8 M (+3.41 %) |
| Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 73,200 | 623,664 | 2,220,692 | 2.1 M to 2.2 M (+3.41 %) |
| Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | S | 7.51 | 323,900 | 2,432,489 | 0 | |
| Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | S | 7.51 | 178,100 | 1,337,531 | 0 | |
| Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | J | 7.51 | 460,400 | 3,457,604 | 0 | |
| Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | J | 7.51 | 264,600 | 1,987,146 | 0 |
Page: 1